Wells Fargo & Company Matinas Bio Pharma Holdings, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.15 - $0.37 $37,245 - $91,871	248,301 Added 232.55%	355,075 $56,000
Q1 2024 May 10, 2024	SELL	$0.19 - $0.3 $23,744 - $37,491	-124,973 Reduced 53.93%	106,774 $28,000
Q4 2023 Feb 09, 2024	SELL	$0.12 - $0.64 $32,989 - $175,944	-274,913 Reduced 54.26%	231,747 $50,000
Q3 2023 Nov 13, 2023	SELL	$0.12 - $0.41 $7,186 - $24,554	-59,890 Reduced 10.57%	506,660 $65,000
Q2 2023 Aug 15, 2023	BUY	$0.35 - $0.72 $195,991 - $403,182	559,975 Added 8516.73%	566,550 $203,000
Q1 2023 May 12, 2023	BUY	$0.39 - $0.6 $8 - $13	23 Added 0.35%	6,575 $3,000
Q4 2022 Feb 13, 2023	SELL	$0.46 - $42.69 $6,619 - $614,309	-14,390 Reduced 68.71%	6,552 $3,000
Q3 2022 Nov 14, 2022	BUY	$0.63 - $33.0 $85 - $4,488	136 Added 0.65%	20,942 $13,000
Q2 2022 Aug 12, 2022	BUY	$0.63 - $0.96 $68 - $103	108 Added 0.52%	20,806 $16,000
Q1 2022 May 16, 2022	BUY	$0.5 - $1.06 $2 - $4	4 Added 0.02%	20,698 $17,000
Q4 2021 Feb 14, 2022	BUY	$0.92 - $1.22 $928 - $1,230	1,009 Added 5.13%	20,694 $21,000
Q3 2021 Nov 15, 2021	BUY	$0.67 - $1.51 $11,136 - $25,097	16,621 Added 542.46%	19,685 $26,000
Q2 2021 Aug 16, 2021	SELL	$0.75 - $1.1 $11,763 - $17,252	-15,684 Reduced 83.66%	3,064 $3,000
Q1 2021 May 13, 2021	SELL	$0.96 - $1.74 $280,083 - $507,651	-291,754 Reduced 93.96%	18,748 $20,000
Q4 2020 Feb 09, 2021	SELL	$0.76 - $1.47 $47,921 - $92,690	-63,055 Reduced 16.88%	310,502 $422,000
Q3 2020 Nov 05, 2020	SELL	$0.67 - $0.96 $129,038 - $184,891	-192,595 Reduced 34.02%	373,557 $286,000
Q2 2020 Aug 13, 2020	BUY	$0.52 - $0.92 $38,820 - $68,681	74,654 Added 15.19%	566,152 $437,000
Q1 2020 May 14, 2020	BUY	$0.6 - $2.31 $294,898 - $1.14 Million	491,498 New	491,498 $295,000

Others Institutions Holding MTNB

# of Institutions

Shares Held

3.52M

Call Options Held

Put Options Held

View Full List

About Matinas BioPharma Holdings, Inc.

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $130M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

More about MTNB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account